Impairing activation of phospholipid synthesis by c-Fos interferes with glioblastoma cell proliferation.

The Biochemical Journal
César Germán PruccaBeatriz L Caputto

Abstract

Glioblastoma multiforme is the most aggressive type of tumor of the CNS with an overall survival rate of approximately one year. Since this rate has not changed significantly over the last 20 years, the development of new therapeutic strategies for the treatment of these tumors is peremptory. The over-expression of the proto-oncogene c-Fos has been observed in several CNS tumors including glioblastoma multiforme and is usually associated with a poor prognosis. Besides its genomic activity as an AP-1 transcription factor, this protein can also activate phospholipid synthesis by a direct interaction with key enzymes of their metabolic pathways. Given that the amino-terminal portion of c-Fos (c-Fos-NA: amino acids 1-138) associates to but does not activate phospholipid synthesizing enzymes, we evaluated if c-Fos-NA or some shorter derivatives are capable of acting as dominant-negative peptides of the activating capacity of c-Fos. The over-expression or the exogenous administration of c-Fos-NA to cultured T98G cells hampers the interaction between c-Fos and PI4K2A, an enzyme activated by c-Fos. Moreover, it was observed a decrease in tumor cell proliferation rates in vitro and a reduction in tumor growth in vivo when a U87-MG-gener...Continue Reading

References

Dec 10, 1991·Biochimica Et Biophysica Acta·P Angel, M Karin
Mar 1, 1995·Journal of Neurobiology·T Curran, J I Morgan
Jan 1, 1996·Journal of Neuroscience Research·M E GuidoB L Caputto
Nov 26, 1996·Proceedings of the National Academy of Sciences of the United States of America·J HuwylerW M Pardridge
Mar 22, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·D F BussolinoB L Caputto
Jun 13, 2001·Oncogene·E Shaulian, M Karin
Feb 10, 2004·Molecular Biology of the Cell·Germán A GilBeatriz L Caputto
Nov 27, 2004·Journal of Cell Science·Jochen HessMarina Schorpp-Kistner
Oct 4, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Karin Milde-Langosch
Nov 6, 2007·Biophysical Journal·Michelle A DigmanEnrico Gratton
Aug 2, 2008·The New England Journal of Medicine·Patrick Y Wen, Santosh Kesari
Jun 10, 2009·International Journal of Pharmaceutics·Eva Horn MoellerJesper Østergaard
Apr 24, 2010·Nature Reviews. Cancer·Tom D Bunney, Matilda Katan
Oct 15, 2011·Molecular Biology of the Cell·Adolfo R Alfonso PecchioBeatriz L Caputto
Jan 24, 2012·Methods in Enzymology·Yuansheng SunRichard N Day
Apr 6, 2012·Neurochemical Research·Germán A GilBeatriz L Caputto
May 29, 2013·IUBMB Life·Andrés M Cardozo Gizzi, Beatriz L Caputto
Dec 3, 2014·Drug Discovery Today·Keld Fosgerau, Torsten Hoffmann
Dec 23, 2014·Nature Reviews. Molecular Cell Biology·Peter E Wright, H Jane Dyson
Jul 6, 2015·Oncotarget·Fabiola N VelazquezBeatriz L Caputto
Oct 18, 2015·The Journal of Biological Chemistry·Andres M Cardozo GizziBeatriz L Caputto
Jan 30, 2016·Science Advances·Dinorah Friedmann-MorvinskiInder M Verma
Apr 17, 2017·Oncotarget·Anna Shteinfer-KuzmineVarda Shoshan-Barmatz
Apr 11, 2018·Journal of Molecular Biology·Rebecca B BerlowPeter E Wright
May 14, 2018·Mechanisms of Development·Carlos Alfonso-Gonzalez, Juan Rafael Riesgo-Escovar
Feb 19, 2019·Current Opinion in Pharmacology·Drazen Raucher
May 28, 2019·Frontiers in Cellular Neuroscience·Lucia Rodríguez-Berdini, Beatriz L Caputto

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.